Treatment of hairy cell leukemia patients with 2-chloro-2'-deoxyadenosine (2-CdA).
A preliminary study of six hairy cell leukemia patients treated with one course of 2-chloro-2'-deoxyadenosine (2-CdA) is presented. 2-CdA was administered 0.1 mg/kg/daily by intravenous infusion over 7 days. Two patients achieved CR and four PR.
Komarnicki
M
M
Department of Hematology, Medical Academy, Poznań, Poland.
Kaźmierczak
M
M
Hansz
J
J
D000328:Adult; D017338:Cladribine / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007943:Leukemia, Hairy Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D017338:Cladribine